Abstract:447 Background: One of the most aggressive forms among the kidney cancer is sarcomatoid and rhabdoid (S/R) renal cell carcinoma (RCC). There is still no effective treatment, and new therapies are needed. In this study, we focused on CD73 and A2aR, which regulate Treg involved in immune escape, and examined them clinicopathologically. Methods: We reviewed a total 1390 formalin-fixed, paraffin-embedded specimens of surgically resected RCC between 1989 and 2016. We detected 60 cases of RCC with sarcomatoid changes and rhabdoid features. We performed immunohistochemistry of CD73, A2aR, PD-L1, and CD8. We attempted to examine clinicopathological significance of CD73- and A2aR- positive RCC with S/R RCCs. The relationship between clinical and pathological features was evaluated using Wilcoxon’s rank sum and Fisher’s exact tests. A Cox proportional hazards regression model was used for multivariate analysis. Both PFS and OS were analyzed by using the Kaplan-Meier method and compared by the Wilcoxon’s rank test. All statistically significances were defined as P<0.05. Results: High-grade components were sarcomatoid changes (31 cases, 51.7%), rhabdoid features (16 cases, 21.7%), and both sarcomatoid and rhabdoid (13 cases, 21.7%). CD73 expression in the high-grade component was observed in 41 cases (68.3%), and A2aR expression was observed in 27 cases (45%). Significant differences among cMstage and high-grade components, sarcomatoid and rhabdoid, are detected in A2aR positive cases, respectively (p=0.0368, 0.0396, 0.0187). The univariate analysis showed a significantly poorer OS for patients whose tumors expressed CD73 and A2aR ( P = 0.0109 and P < .0001). To validate this finding further, a multivariate analysis was performed using the Cox proportional hazards model). The results indicated that A2aR expression ( P = 0.0206) and pTstage ( P = 0.0433) were independent markers for unfavorable prognosis in S/R RCCs. CD73 and A2aR expressions were significantly related to poor PFS ( P = 0.0395, P = 0.0043, respectively). CD73 and A2aR expressions were significantly related to poor OS ( P = 0.0188, P < .0001, respectively). Conclusions: CD73 and A2aR expression correlated with the poorest prognosis group among S/R RCCs, indicating that the use of inhibitors against them in combination with conventional therapies may improve prognosis.

Significance of CD73/adenosine receptor 2 (A2aR) and immune microenvironmental status in renal cell carcinoma with sarcomatoid changes and rhabdoid features.